Navigation Links
Simcere Pharmaceutical Group Reports Preliminary Unaudited First Quarter 2010 Results
Date:5/18/2010

xin. Simcere manufactures and sells antibiotics, anti-cancer medication, stroke management medication and biopharmaceutical drugs such as vaccines. Simcere concentrates its research and development efforts on the treatment of diseases with high incidence and/or mortality rates and for which there is a clear demand for more effective pharmacotherapy such as cancer, strokes, orthopaedics and infectious diseases. For more information about Simcere Pharmaceutical Group, please visit http://www.simcere.com .



    SIMCERE PHARMACEUTICAL GROUP
    PRELIMINARY UNAUDITED CONDENSED CONSOLIDATED STATEMENTS OF INCOME
    (AMOUNTS EXPRESSED IN THOUSANDS, EXCEPT SHARE AND ADS DATA)

                                              Three months ended March 31,
                                            2009           2010        2010
                                             RMB            RMB         USD

    Product revenue                       436,633        457,648      67,047
    Other revenue                           5,873          1,021         150
    Total revenue                         442,506        458,669      67,197
    Cost of materials and production      (77,320)       (93,096)    (13,639)
    Gross profit                          365,186        365,573      53,558

    Operating expenses:
    Research and development expenses     (25,047)       (30,592)     (4,482)
    Sales, marketing and
     distribution expenses               (219,779)      (236,879)    (34,704)
    General and administrative
     expenses                             (59,288)       (67,240)     (9,851)
    Income from operations                 61,072         30,862       4,521

    Interest income                         2,569          1,296         190
    Interest 
'/>"/>
SOURCE Simcere Pharmaceutical Group
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10 11 12

Related medicine technology :

1. Simceres Diosmectite API Passes EU-GMP Inspection
2. Simcere Pharmaceutical Group Successfully Completes Endostar Phase IV Clinical Study
3. Simcere Pharmaceutical Group to Announce Fourth Quarter and Fiscal Year 2009 Unaudited Financial Results on Tuesday, March 16, 2010
4. Simcere Receives SFDA Approval to Manufacture and Sell Zanamivir in China
5. Simcere Pharmaceutical Group Provides Update on Jiangsu Yanshen
6. Simcere Pharmaceutical Group Announces Jiangsu Yanshens Voluntary Suspension of Production
7. Simcere Pharmaceutical Group to Acquire Additional Stake in Jiangsu Yanshen Biological Technology Stock Co., Ltd.
8. Simcere Pharmaceutical Group Announces Collaboration with OSI Pharmaceuticals
9. Simcere Pharmaceutical Group Announces Interim Results of Endu Phase IV Clinical Study
10. Epix Pharmaceuticals, Inc. Announces Additional Information Concerning the May 28, 2010 Auction Sale of EP-3600 MRI Imaging Agent
11. Isis Pharmaceuticals to Discuss Its Cancer Franchise in a Conference Call on Wednesday, May 19
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/28/2015)... and Company (NYSE: LLY ) announced today the pricing ... to $1.6 billion aggregate principal amount of certain of its ... and did not validly withdraw, their notes on or before ... on May 27, 2015 (the early tender date), and which ... the total consideration. The total consideration for each series of ...
(Date:5/28/2015)... 28, 2015  Pharmaceutical companies and diagnostics ... tests, and this is translating into a ... assist them. This according to Kalorama Information, a ... such as mass spectrometry, electrophoresis and liquid ... of drug targets and the validation of ...
(Date:5/28/2015)... MELVILLE, N.Y. , May 28, 2015 /PRNewswire/ ... ), the world,s largest provider of health care ... and medical practitioners, today reminded its customers that ... for dentists, physicians and veterinarians who experience operational, ... the disastrous storms in the South Central region ...
Breaking Medicine Technology:Lilly Announces the Pricing Terms of Its Cash Tender Offer for Up to $1.6 Billion Aggregate Principal Amount of Its Outstanding Debt Securities 2Lilly Announces the Pricing Terms of Its Cash Tender Offer for Up to $1.6 Billion Aggregate Principal Amount of Its Outstanding Debt Securities 3Lilly Announces the Pricing Terms of Its Cash Tender Offer for Up to $1.6 Billion Aggregate Principal Amount of Its Outstanding Debt Securities 4Lilly Announces the Pricing Terms of Its Cash Tender Offer for Up to $1.6 Billion Aggregate Principal Amount of Its Outstanding Debt Securities 5Report: Proteomics Research Market Reaches $1.6 Billion 2Report: Proteomics Research Market Reaches $1.6 Billion 3Henry Schein Disaster Relief Hotline Is Open To Support Customers Affected By Storms In South Central, U.S. 2Henry Schein Disaster Relief Hotline Is Open To Support Customers Affected By Storms In South Central, U.S. 3
(Date:5/29/2015)... North Carolina (PRWEB) May 29, 2015 ... confirmed that the newest Red Hot & Blue restaurant at ... business on Thursday, May 7, 2015. “The Red Hot & ... center for 18 years, but we have moved to a ... are now in the middle of all the activities on ...
(Date:5/29/2015)... Miss. (PRWEB) May 29, 2015 ... announced the graduates of its Advanced Training Program ... students, who fill roles in their health care ... the theory and methodology of continuous quality improvement ... a sister-program to Dr. Brent James’ internationally recognized ...
(Date:5/29/2015)... Inspire Nexus, a new social network officially ... question many life coaches have asked, "How do I ... necessary to become a credentialed Coach?" , Many Life ... for long. Inspire Nexus, a social network for Coaches ... who have experience coaching a certain number of hours, ...
(Date:5/29/2015)... May 29, 2015 The campaign focuses ... as a number of specific concerns within, including the ... and mental health in the workplace. We are encouraged ... The campaign also brings special focus to people living ... speak up and seek help from healthcare professionals and ...
(Date:5/29/2015)... The report “Muscle Spasm – ... the therapeutic development for Muscle Spasm. Spasms may ... body, leading to many different symptoms and presentations. ... targets and MOAs to produce first-in-class and best-in-class ... of Axillary Hyperhidrosis with 19 market data tables ...
Breaking Medicine News(10 mins):Health News:Red Hot & Blue Restaurant Opens in Cary, North Carolina 2Health News:Red Hot & Blue Restaurant Opens in Cary, North Carolina 3Health News:Red Hot & Blue Restaurant Opens in Cary, North Carolina 4Health News:HORNE LLP’s Healthcare Delivery Institute Graduates Class from the Advanced Training Program 2Health News:Mediaplanet Brings Activism to Those Living with Mental Illness in Bew “Mental Health Awareness” Campaign 2Health News:Muscle Spasm Therapeutic Development Pipeline Review H1 2015 Market Research Report Available at RnRMarketResearch.com 2Health News:Muscle Spasm Therapeutic Development Pipeline Review H1 2015 Market Research Report Available at RnRMarketResearch.com 3Health News:Muscle Spasm Therapeutic Development Pipeline Review H1 2015 Market Research Report Available at RnRMarketResearch.com 4
... patients battling stomach cancer , , THURSDAY, Dec. 13 (HealthDay ... (Sutent), which fights stomach tumors, can also create heart ... , All patients taking sunitinib, but especially those who ... treatment for high blood pressure and other signs of ...
... Safety extension study to be part of NDA submission ... (ASX: QRX),announced today the initiation of a second Phase ... immediate release dual-opioid pain,therapy. This placebo controlled, double blind ... safety data in support of the,Company,s submission of a ...
... N.Y., Dec. 13 Capsulated Systems, Inc. at ... a new proprietary,micro-particle system that provides prolonged post-operative ... according to its president and,co-inventor, Roland Lynch. This ... an Ithaca, NY orthopedic surgeon, for a long ...
... Dec. 13, Speaker Nancy Pelosi,issued the following statement ... Leader George Mitchell, which found widespread use,of steroids and ... Mitchell Report tells a troubling story of how many ... the fans of our national,pastime by using steroids and ...
... Seniors Want E-Prescribing in Medicare, WASHINGTON, Dec. ... promoting electronic prescribing (e-prescribing) in,Medicare is emerging as ... on. "The Medicare Electronic Medication and Safety Protection,(E-MEDS) ... physicians begin to,prescribe electronically, will save lives and ...
... College of Nursing has received a federal grant to create ... end of life. , The UIC Center for End-of-Life ... of all ages facing death -- infants, children, adults and ... from the National Institute of Nursing Research, one of the ...
Cached Medicine News:Health News:New Cancer Drug Tied to Heart Problems 2Health News:New Cancer Drug Tied to Heart Problems 3Health News:New Cancer Drug Tied to Heart Problems 4Health News:QRxPharma Initiates Second Phase III Clinical Trial for its 'Dual Opioid' Pain Therapy 2Health News:Capsulated Systems, Inc. Develops Long Term Local Anesthetic 2Health News:One Thing Washington Can Agree On: Time for E-Prescribing in Medicare 2Health News:One Thing Washington Can Agree On: Time for E-Prescribing in Medicare 3Health News:New UIC center to study end-of-life transition 2Health News:New UIC center to study end-of-life transition 3
... total knee manufacturers focus attention on implant ... instrumentation. The Profix Total Knee System seeks ... knee implant system and the tools to ... M.D., widely recognized for innovation in total ...
Cementless hip system...
Simplified Design-Based on 15 Years of Experience...
... Unicompartmental knee arthroplasty has proven to ... tibial osteotomy and total knee arthroplasty ... is a minimally invasive unicompartmental knee ... surgery. Using the latest conservative ...
Medicine Products: